Process View
The switching of activated B cells from IgM biosynthesis to biosynthesis of other isotypes of immunoglobulin, accomplished through a recombination process involving an intrachromosomal deletion involving switch regions that reside 5' of each constant region gene segment in the immunoglobulin heavy chain locus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "isotype switching"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| MSH6 | mutS homolog 6 (E. coli) | 0.960 | Mouse | |
| MRE11A | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | 0.921 | ||
| BRCA1 | breast cancer 1, early onset | 0.908 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.877 | ||
| APLF | aprataxin and PNKP like factor | 0.822 | ||
| IL4R | interleukin 4 receptor | 0.802 | ||
| MDC1 | mediator of DNA-damage checkpoint 1 | 0.729 | ||
| MSH2 | mutS homolog 2, colon cancer, nonpolyposis type 1 (E. coli) | 0.652 | Mouse | |
| H2AFX | H2A histone family, member X | 0.512 | ||
| MSH3 | mutS homolog 3 (E. coli) | 0.503 | ||
| PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.463 | ||
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.364 | ||
| BRIP1 | BRCA1 interacting protein C-terminal helicase 1 | 0.293 | ||
| MLH1 | mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) | 0.269 | Mouse | |
| GRAP2 | GRB2-related adaptor protein 2 | 0.250 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.208 | ||
| NBN | nibrin | 0.204 | Mouse | |
| IL2RG | interleukin 2 receptor, gamma | 0.194 | ||
| RBBP8 | retinoblastoma binding protein 8 | 0.150 | ||
| PMS2 | PMS2 postmeiotic segregation increased 2 (S. cerevisiae) | 0.141 | ||
| PMS1 | PMS1 postmeiotic segregation increased 1 (S. cerevisiae) | 0.140 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.125 | ||
| THOC5 | THO complex 5 | 0.120 | ||
| RFC1 | replication factor C (activator 1) 1, 145kDa | 0.111 | ||
| TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.102 | ||
| EXO1 | exonuclease 1 | 0.101 | Mouse | |
| ZNF830 | zinc finger protein 830 | 0.095 | ||
| XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.078 | Mouse | |
| DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B | 0.076 | ||
| ENG | endoglin | 0.068 | ||
| ATR | ataxia telangiectasia and Rad3 related | 0.062 | ||
| RAD1 | RAD1 homolog (S. pombe) | 0.057 | ||
| HDAC9 | histone deacetylase 9 | 0.056 | ||
| BARD1 | BRCA1 associated RING domain 1 | 0.053 | ||
| PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.051 | ||
| CD22 | CD22 molecule | 0.047 | ||
| HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 0.043 | ||
| SMC1A | structural maintenance of chromosomes 1A | 0.038 | ||
| NHEJ1 | nonhomologous end-joining factor 1 | 0.037 | ||
| INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.037 | ||
| ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.035 | ||
| IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.035 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.033 | ||
| SUPT5H | suppressor of Ty 5 homolog (S. cerevisiae) | 0.032 | ||
| POLR2A | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | 0.031 | ||
| RUNX1 | runt-related transcription factor 1 | 0.031 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.030 | ||
| SEMA4D | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D | 0.030 | ||
| LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.029 | ||
| THOC4 | THO complex 4 | 0.029 | ||
| NASP | nuclear autoantigenic sperm protein (histone-binding) | 0.028 | ||
| PCDH9 | protocadherin 9 | 0.027 | ||
| RNF11 | ring finger protein 11 | 0.026 | ||
| FRA10AC1 | fragile site, folic acid type, rare, fra(10)(q23.3) or fra(10)(q24.2) candidate 1 | 0.025 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.024 | ||
| HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.023 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.022 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.021 | ||
| THOC2 | THO complex 2 | 0.021 | ||
| PRKCQ | protein kinase C, theta | 0.021 | ||
| BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 0.020 | ||
| STRN4 | striatin, calmodulin binding protein 4 | 0.020 | ||
| TOPBP1 | topoisomerase (DNA) II binding protein 1 | 0.019 | ||
| TTI1 | Tel2 interacting protein 1 homolog (S. pombe) | 0.019 | ||
| DTL | denticleless homolog (Drosophila) | 0.019 | ||
| LAPTM5 | lysosomal protein transmembrane 5 | 0.019 | ||
| ANKRD13A | ankyrin repeat domain 13A | 0.018 | ||
| TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.018 | ||
| LIG4 | ligase IV, DNA, ATP-dependent | 0.018 | Mouse | |
| POLD3 | polymerase (DNA-directed), delta 3, accessory subunit | 0.017 | ||
| XRCC6 | X-ray repair complementing defective repair in Chinese hamster cells 6 | 0.017 | ||
| PTPN22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.017 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.017 | ||
| RPP14 | ribonuclease P/MRP 14kDa subunit | 0.016 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.016 | ||
| GBF1 | golgi brefeldin A resistant guanine nucleotide exchange factor 1 | 0.016 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.016 | ||
| RNF8 | ring finger protein 8 | 0.016 | ||
| CHD8 | chromodomain helicase DNA binding protein 8 | 0.015 | ||
| HDAC7 | histone deacetylase 7 | 0.015 | ||
| THBS1 | thrombospondin 1 | 0.015 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.015 | ||
| IRF4 | interferon regulatory factor 4 | 0.015 | ||
| FANCI | Fanconi anemia, complementation group I | 0.015 | ||
| SYK | spleen tyrosine kinase | 0.015 | ||
| ARAP1 | ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1 | 0.015 | ||
| KNTC1 | kinetochore associated 1 | 0.014 | ||
| SMARCAD1 | SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1 | 0.014 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.014 | ||
| HDAC5 | histone deacetylase 5 | 0.014 | ||
| TRAF5 | TNF receptor-associated factor 5 | 0.014 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.014 | ||
| SH2D2A | SH2 domain containing 2A | 0.013 | ||
| DCLRE1A | DNA cross-link repair 1A | 0.013 | ||
| MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.013 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.013 | ||
| CHEK1 | CHK1 checkpoint homolog (S. pombe) | 0.013 | ||
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 0.013 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.013 | ||
| XAB2 | XPA binding protein 2 | 0.013 | ||
| HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.013 | ||
| POLA1 | polymerase (DNA directed), alpha 1, catalytic subunit | 0.013 | ||
| NRP1 | neuropilin 1 | 0.013 | ||
| PCNA | proliferating cell nuclear antigen | 0.012 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.012 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.012 | ||
| NONO | non-POU domain containing, octamer-binding | 0.012 | ||
| MEF2C | myocyte enhancer factor 2C | 0.012 | ||
| CWC27 | CWC27 spliceosome-associated protein homolog (S. cerevisiae) | 0.012 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.012 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.012 | ||
| HUS1 | HUS1 checkpoint homolog (S. pombe) | 0.012 | ||
| DNAJC9 | DnaJ (Hsp40) homolog, subfamily C, member 9 | 0.012 | ||
| E2F3 | E2F transcription factor 3 | 0.012 | ||
| SLC39A7 | solute carrier family 39 (zinc transporter), member 7 | 0.011 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.011 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.011 | ||
| RCN3 | reticulocalbin 3, EF-hand calcium binding domain | 0.011 | ||
| ATRX | alpha thalassemia/mental retardation syndrome X-linked | 0.011 | ||
| RBBP4 | retinoblastoma binding protein 4 | 0.011 | ||
| BLM | Bloom syndrome, RecQ helicase-like | 0.011 | ||
| SH2D1A | SH2 domain containing 1A | 0.011 | ||
| CD2 | CD2 molecule | 0.011 | ||
| LITAF | lipopolysaccharide-induced TNF factor | 0.011 | ||
| IK | IK cytokine, down-regulator of HLA II | 0.011 | ||
| CLSPN | claspin | 0.011 | ||
| ING2 | inhibitor of growth family, member 2 | 0.010 | ||
| MAX | MYC associated factor X | 0.010 | ||
| SUZ12 | suppressor of zeste 12 homolog (Drosophila) | 0.010 | ||
| AR | androgen receptor | 0.010 | ||
| CTDP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) phosphatase, subunit 1 | 0.010 | ||
| CD7 | CD7 molecule | 0.010 | ||
| ME2 | malic enzyme 2, NAD(+)-dependent, mitochondrial | 0.010 | ||
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.010 |